Breast Cancer Research Foundation

Here’s what experts want you to know about the treatment. Table of contentsWhat is cryoablation for breast cancer?When is cryoablation for breast ...

This year’s American Society of Clinical Oncology (ASCO) delved into exciting clinical trials for various types of breast cancer, GLP-1 use, and more. Key takeaways Adding chemotherapy to endocrine therapy provided no added benefit for some patients at high clinical risk of breast cancer, according to a study. Promising results from several clinical trials expand the ...

Key takeaways Katie Thurston opened up about being diagnosed with stage 4 breast cancer. She shared the most surprising aspect of her diagnosis at the Breast Cancer Research Foundation’s Hot Pink Party. “I think a lot of us are feeling lumps but thinking, ‘It’s [breast changes due to] our period.’ Well, sometimes it’s not. Sometimes it’s cancer.”

Former

The exciting trial was discussed at ASCO’s annual meeting. Key Takeaways Some people with high-risk breast cancer may be able to safely forgo chemotherapy thanks to a genomic test developed based on BCRF work, according to a new study. The study, known as the OPTIMA trial, showed adding chemotherapy to endocrine therapy provided no added benefit to some patients with ...

The drug was approved for people who are not eligible for immunotherapy. Key Takeaways Datroway (Dato-DXd, or datopotamab deruxtecan) is the first TROP-2 directed antibody-drug conjugate FDA approved for women with metastatic or unresectable triple-negative breast cancer. Specifically, patients who are ineligible for immunotherapy may be candidates for Datroway, givin...